Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Maura Di Vito is active.

Publication


Featured researches published by Maura Di Vito.


Journal of Neuroinflammation | 2011

Pro-inflammatory gene expression in solid glioblastoma microenvironment and in hypoxic stem cells from human glioblastoma

Marco Tafani; Maura Di Vito; Alessandro Frati; Laura Pellegrini; Elena De Santis; Giovanni Sette; Adriana Eramo; Patrizio Sale; Emanuela Mari; Antonio Santoro; Antonino Raco; Maurizio Salvati; Ruggero De Maria; Matteo A. Russo

BackgroundAdaptation to hypoxia and consequent pro-inflammatory gene expression of prostate and breast carcinomas have been implicated in the progression toward cancer malignant phenotype. Only partial data are available for the human tumor glioblastoma multiforme (GBM). The aim of our study was to analyze the hypoxic and pro-inflammatory microenvironment in GBMs and to demonstrate that in a stem/progenitor cell line derived from human glioblastoma (GBM-SCs), hypoxia activates a coordinated inflammatory response, evidencing an invasive and migratory phenotype.MethodsFrom each of 10 human solid glioblastomas, clinically and histopathologically characterized, we obtained three surgical samples taken from the center and the periphery of the tumor, and from adjacent host normal tissue. Molecular and morphological analyses were carried out using quantitative real-time PCR and western blot (WB). GBM stem and differentiated cells were incubated under hypoxic conditions and analyzed for pro-inflammatory gene expression and for invasive/migratory behavior.ResultsA panel of selected representative pro-inflammatory genes (RAGE and P2X7R, COX2, NOS2 and, PTX3) were analyzed, comparing tumor, peritumor and host normal tissues. Tumors containing leukocyte infiltrates (as assessed using CD45 immunohistochemistry) were excluded. Selected genes were overexpressed in the central regions of the tumors (i.e. in the more hypoxic areas), less expressed in peripheral regions, and poorly expressed or absent in adjacent normal host tissues. Western blot analysis confirmed that the corresponding pro-inflammatory proteins were also differently expressed. Hypoxic stem cell lines showed a clear time-dependent activation of the entire panel of pro-inflammatory genes as compared to differentiated tumor cells. Biological assays showed that invasive and migratory behavior was strengthened by hypoxia only in GBM stem cells.ConclusionsIn human solid glioblastoma we have observed a coordinated overexpression of a panel of pro-inflammatory genes as compared to host normal tissue. We have also evidenced a similar pattern of overexpressed genes in GBM-SCs after hypoxic treatment, showing also a gain of invasive and migratory function that was lost when these stem cells differentiated. We suggest that, as has been previously described for prostatic and mammary carcinoma, in human glioblastoma acquisition of a proinflammatory phenotype may be relevant for malignant progression.


Cancer Science | 2010

Up-regulation of pro-inflammatory genes as adaptation to hypoxia in MCF-7 cells and in human mammary invasive carcinoma microenvironment

Marco Tafani; Andrea M. Russo; Maura Di Vito; Patrizio Sale; Laura Pellegrini; Luana Schito; Stefano Gentileschi; Roberto Bracaglia; Ferdinando Marandino; Enrico Garaci; Matteo A. Russo

The role of tumor cells in synthesizing pro‐inflammatory molecules is still controversial. Here we report that hypoxic treatment of the MCF‐7 human mammary adenocarcinoma cell line induced activation of hypoxia‐inducible factor 1α (HIF‐1α) and nuclear factor‐kappa B (NF‐κB). Importantly, hypoxia regulated expression of alarmin receptors such as the receptor for advanced glycation end products (RAGE) and the purinoreceptor (P2X7R), and up‐regulated inflammatory response (IR) genes such as the inducible enzymes nitric oxide synthase (NOS2), cycloxygenase (COX2), and the acute‐phase protein pentraxin‐3 (PTX3). Hypoxia also stimulated chemokine (C‐X‐C motif) receptor 4 (CXCR4) mRNA synthesis. In fact, the CXCR4 ligand stromal‐derived factor‐1α (SDF‐1α) increased invasion and migration of hypoxic MCF‐7 cells. Inhibition of HIF‐1α by chetomin and NF‐κB by parthenolide reduced mRNA and protein expression of the studied molecules and prevented invasion of hypoxic MCF‐7 cells. Moreover, solid invasive mammary tumor microenvironment was analyzed after laser‐capture microdissection (LCMD) comparing tumor versus host normal tissue. Nuclear translocation of HIF‐1α and NF‐κB and up‐regulation of IR, CXCR4, estrogen receptor α (ERα), and epithelial growth factor receptor (EGFR) was observed in tumor but not in host normal tissue in the absence of a local inflammatory leukocyte infiltrate. We conclude that under hypoxic conditions MCF‐7 cells acquire a pro‐inflammatory phenotype, and that solid human mammary carcinoma evidenced a similar activation of HIF‐1α, NF‐κB, and IR genes in malignant tumor cells as compared to the normal host tissues. We suggest a role for IR activation in the malignant progression of transformed cells.


American Journal of Physiology-endocrinology and Metabolism | 2010

17β-Estradiol modulates the macrophage migration inhibitory factor secretory pathway by regulating ABCA1 expression in human first-trimester placenta

Francesca Ietta; Nicoletta Bechi; Roberta Romagnoli; Jayonta Bhattacharjee; Massimo Realacci; Maura Di Vito; Cristina Ferretti; Luana Paulesu

Successful pregnancy involves a series of events, most of them mediated by hormones and cytokines. Estrogens, besides being important for placental growth and embryo development, have a marked effect on the immune system exerting either pro- or anti-inflammatory properties. Numerous studies suggest that estrogens directly affect cellular function, including cytokine production. Macrophage migration inhibitory factor (MIF) is a proinflammatory cytokine involved in pregnancy, particularly during the earlier stages of placentation. Since reports on mice have shown that estrogens modulate MIF, herein we investigated the effect of estrogens on human placental MIF. By using an in vitro model of first-trimester chorionic villous explants, we found that 17beta-estradiol (E(2)) was able to modulate the release of MIF in a dose-dependent manner (10(-12) vs. 10(-9) M, P < 0.05; 10(-9) vs. 10(-5) M, P < 0.05; 10(-12) vs. 10(-5) M, P < 0.001). Unlike MIF release, no significant change in tissue MIF protein or MIF mRNA was observed. We showed evidence that E(2) concentrations (10(-9) and 10(-5) M) act on placental tissue downregulating the mRNA and protein expression of the ATP-binding cassette transporter protein A1, a membrane transporter involved in MIF secretion. These findings emphasize the mutual cooperation between hormones and cytokines and suggest that increasing estrogen levels with advancing gestation may have a major role in regulating placental MIF secretion.


Cancer Science | 2011

Overexpression of estrogen receptor-α in human papillary thyroid carcinomas studied by laser- capture microdissection and molecular biology.

Maura Di Vito; Elena De Santis; Giulietta A. Perrone; Emanuela Mari; Maria Chiara Giordano; Enrico De Antoni; Luigi Coppola; Guido Fadda; Marco Tafani; Angelo Carpi; Matteo A. Russo

The expression pattern of estrogen receptor (ER) isoforms in normal and tumor thyroid tissues is still controversial and poor defined, therefore, a more detailed study of the distribution of these molecules is needed. Most discrepancies might be due to the methods utilized. We studied the expression of ER isoforms in human papillary thyroid carcinoma (PTC), in fine‐needle aspiration biopsy‐derived specimens, and in cells, using more accurate techniques, such as laser‐capture microdissection, real‐time quantitative PCR, and Western blot. Laser‐capture microdissection allowed us to isolate homogeneous cell populations from human PTC surgical samples. Tumor, peritumor, or normal host tissue of the same sample were separately dissected and analyzed by RT‐PCR and Western blot. Estrogen receptor‐α mRNA was more expressed in cancer‐microdissected cells from human PTC, as compared with microdissected cells obtained from surrounding normal host tissue (450 vs 12, P = 0.001). A similar pattern was observed with Western blot for the ER‐α protein. By contrast, ER‐β mRNA expression was not detected among the microdissected tissue fractions. Fine‐needle aspiration biopsy‐derived specimens showed a similar expression pattern to ER. Moreover, human PTC cell line BCPAP and cancer stem cells from PTC, analyzed under hypoxic conditions, showed a hypoxia‐driven increase in ER‐α expression. In conclusion, ER‐α might have an important role in human PTC, and its overexpression can be studied in routine needle aspirate as a possible marker of malignancy. (Cancer Sci 2011; 102: 1921–1927)


Free Radical Research | 2007

Reactive oxygen and nitrogen species are involved in sorbitol-induced apoptosis of human erithroleukaemia cells K562

Katia Aquilano; Giuseppe Filomeni; Livia Di Renzo; Maura Di Vito; Carla Di Stefano; Paola Sinibaldi Salimei; Maria Rosa Ciriolo; Gabriella Marfe

In this study, we found that production of both reactive oxygen (ROS) and nitrogen (RNS) species is a very early event related to treatment with hyperosmotic concentration of sorbitol. The production of nitric oxide (NO) was paralleled by the increase of the mRNA and protein level of the inducible form of the nitric oxide synthase (iNOS). ROS and RNS enhancement, process concomitant to the failure of mitochondrial trans-membrane potential (ΔΨ), was necessary for the induction of apoptosis as demonstrated by the protection against sorbitol-mediated toxicity observed after treatment with ROS scavengers or NOS inhibitors. The synergistic action of ROS and RNS was finally demonstrated by pre-treatment with rosmarinic acid that, by powerfully buffering both these species, prevents impairment of ΔΨ and cell death. Overall results suggest that the occurrence of apoptosis upon sorbitol treatment is an event mediated by oxidative/nitrosative stress rather than a canonical hyperosmotic shock.


Oncology Reports | 2010

Cross-talk between NO and HMGB1 in lymphocytic thyroiditis and papillary thyroid cancer

Stefania Mardente; Alessandra Zicari; Fabrizio Consorti; Emanuela Mari; Maura Di Vito; Martina Leopizzi; Carlo Della Rocca; Alfredo Antonaci


Journal of Molecular Histology | 2008

OPG and RANKL mRNA and protein expressions in the primary and secondary metaphyseal trabecular bone of PTH-treated rats are independent of that of SOST

G. Silvestrini; P. Ballanti; Mariangela Sebastiani; Martina Leopizzi; Maura Di Vito; E. Bonucci


Biomedicine & Pharmacotherapy | 2013

Overexpression of pro-inflammatory genes and down-regulation of SOCS-1 in human PTC and in hypoxic BCPAP cells

Elena De Santis; Maura Di Vito; Giulietta A. Perrone; Emanuela Mari; Maria Osti; Enrico De Antoni; Luigi Coppola; Marco Tafani; Angelo Carpi; Matteo A. Russo


Anticancer Research | 2006

Detection of oncogenic HPV and identification of 72Arg polymorphic p53 by in situ PCR for clinical routine purposes.

Massimo Realacci; Giulietta A. Perrone; Patrizio Sale; Marco Tafani; Maura Di Vito; Raffaele Perrone-Donnorso; Giancarlo Zotti; Matteo A. Russo

Collaboration


Dive into the Maura Di Vito's collaboration.

Top Co-Authors

Avatar

Marco Tafani

Sapienza University of Rome

View shared research outputs
Top Co-Authors

Avatar

Matteo A. Russo

Sapienza University of Rome

View shared research outputs
Top Co-Authors

Avatar

Emanuela Mari

Sapienza University of Rome

View shared research outputs
Top Co-Authors

Avatar

Elena De Santis

Sapienza University of Rome

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Patrizio Sale

Sapienza University of Rome

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Laura Pellegrini

Sapienza University of Rome

View shared research outputs
Top Co-Authors

Avatar

Martina Leopizzi

Sapienza University of Rome

View shared research outputs
Top Co-Authors

Avatar

Massimo Realacci

Sapienza University of Rome

View shared research outputs
Researchain Logo
Decentralizing Knowledge